(Q40002575)

English

Clinical evaluation of a novel method for the measurement of prostate-specific antigen, AccuPSA(TM) , as a predictor of 5-year biochemical recurrence-free survival after radical prostatectomy: results of a pilot study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Clinical evaluation of a novel method for the measurement of prostate-specific antigen, AccuPSA(TM) , as a predictor of 5-year biochemical recurrence-free survival after radical prostatectomy: results of a pilot study (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

9

object named as

Alan W Partin

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

4

object named as

Samir S Taneja

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

author name string

Herbert Lepor

1

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Carol D Cheli

2

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Robert P Thiel

3

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Juliana Laze

5

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Dan W Chan

6

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Lori J Sokoll

7

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Leslie Mangold

8

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

12 October 2011

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

BJU International

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

109

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

1770-1775

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Biology of prostate-specific antigen

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10568.X

21 January 2018

Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10568.X

21 January 2018

Prostate specific antigen recurrence after definitive therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10568.X

21 January 2018

Does benign prostatic tissue contribute to measurable PSA levels after radical prostatectomy?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10568.X

21 January 2018

Prostate-specific Antigen: Its Usefulness in Clinical Medicine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10568.X

21 January 2018

Prognostic implications of an undetectable ultrasensitive prostate-specific antigen level after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10568.X

21 January 2018

Undetectable ultrasensitive PSA after radical prostatectomy for prostate cancer predicts relapse-free survival.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10568.X

21 January 2018

Simultaneous detection of single molecules and singulated ensembles of molecules enables immunoassays with broad dynamic range

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10568.X

21 January 2018

Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10568.X

21 January 2018

Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10568.X

21 January 2018

Predictive and prognostic models in radical prostatectomy candidates: a critical analysis of the literature

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10568.X

21 January 2018

Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10568.X

21 January 2018

Nanoparticle-based bio-barcode assay redefines "undetectable" PSA and biochemical recurrence after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10568.X

21 January 2018

Detection of Prostate Cancer Relapse With Prostate Specific Antigen Monitoring at Levels of 0.001 to 0.1 micro g./l

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10568.X

21 January 2018

Identifiers

10.1111/J.1464-410X.2011.10568.X

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40002575&oldid=1882298535"